13C Urea Breath Test (UBT) Analyzer for the diagnosis of Helicobacter Pylori Infection

  

Urea Breath Test (UBT) for the diagnosis of Helicobacter Pylori Infection is applied for clinical diagnosis of H. Pylori infection. As ¹³C is a kind of stable isotope, ¹³C Breath Test is applicable for all ages and types of subjects, including pregnant women and young children.

 

  

Specifications:

1. Dimension: 540 mm×404 mm×345 mm;

2. Weight: 18kgs;

3.Power supply: AC220V  50Hz,  power consumption<250W

4. Range of CO2 Concentration: 1.0~6.0%

5. Sample volumn: ≥120ml/bag

6. Measurement time: ≤3minutes/test

7. Accuracy: standard error ≤0.3‰

 

 

Advantages:

 

Accurate
Sensitivity 95%, specificity 95%-100%.
Comfortable
Non-invasive, no endoscopic tube insertion, well tolerated by patients.
Convenient
Near-patient testing, analysis made on site, minimal inconvenience for patients.
Simple
Easy operation, no special handling required.
Swift
The entire test is finished in 45 minutes, test result available on site.

 

 

Product Highlights:

High efficiency
Fast operation, 2-3 minutes for one set of samples
12 channels, automatic batch testing
Simple
One-touch operation, automatic control system
Accurate
Good repeatability, standard error≤0.3‰ 

 

 

Our Service

For agent, not only we support them in products promoting in the local market accoarding to our experience all round the world, but also support in the after-sales services, technical support and products training. If you have some in the local professional association of digestive system, or some influential exhibition, the company will give corresponding support.

 

  

 

Company Information

 

Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., affiliated to China National Nuclear Corporation, is the founder of the breath testing industry in China and is the only high-tech enterprise in China that owns the intellectual property rights to exclusively engage in the development and production of breath test kits and analysis equipment. 

   We have always been committed to innovative research on the development of non-invasive diagnostic breath testing products since our establishment in 1996. 

   With a number of branches spreading over 33 provinces and municipalities in China, we have built up a comprehensive and efficient service network serving over 8,000 hospitals across China.